中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2013年
5期
298-299
,共2页
张颖%于刚%王炎焱%赵伟%张江林
張穎%于剛%王炎焱%趙偉%張江林
장영%우강%왕염염%조위%장강림
复方甘草酸苷%低钾血症%假性醛固酮增多症%药品不良反应
複方甘草痠苷%低鉀血癥%假性醛固酮增多癥%藥品不良反應
복방감초산감%저갑혈증%가성철고동증다증%약품불량반응
Compound glycyrrhizin%Hypopotassemia%Pseudohyperaldosteronism%Adverse drug reaction
1例51岁男性患者,因银屑病性关节炎口服甲氨蝶呤片,治疗过程中出现AST、ALT轻度升高,考虑药物性肝损害,给予复方甘草酸苷片2片,tid。1周后患者出现下肢乏力、行走费力,2周时出现颜面及下肢水肿,BP 160/90 mm Hg,3周时出现上肢乏力、发抖,BP 160/90 mm Hg。停药1周后乏力、行走费力、上肢发抖症状缓解,BP 130/76 mm Hg,血钾1.76 mmol· L-1、代谢性碱中毒。期间无联合用药,查甲功、肾上腺功能等未见异常。经补钾治疗5 d后患者血钾恢复至4.22 mmol· L-1,代谢性碱中毒纠正。
1例51歲男性患者,因銀屑病性關節炎口服甲氨蝶呤片,治療過程中齣現AST、ALT輕度升高,攷慮藥物性肝損害,給予複方甘草痠苷片2片,tid。1週後患者齣現下肢乏力、行走費力,2週時齣現顏麵及下肢水腫,BP 160/90 mm Hg,3週時齣現上肢乏力、髮抖,BP 160/90 mm Hg。停藥1週後乏力、行走費力、上肢髮抖癥狀緩解,BP 130/76 mm Hg,血鉀1.76 mmol· L-1、代謝性堿中毒。期間無聯閤用藥,查甲功、腎上腺功能等未見異常。經補鉀治療5 d後患者血鉀恢複至4.22 mmol· L-1,代謝性堿中毒糾正。
1례51세남성환자,인은설병성관절염구복갑안접령편,치료과정중출현AST、ALT경도승고,고필약물성간손해,급여복방감초산감편2편,tid。1주후환자출현하지핍력、행주비력,2주시출현안면급하지수종,BP 160/90 mm Hg,3주시출현상지핍력、발두,BP 160/90 mm Hg。정약1주후핍력、행주비력、상지발두증상완해,BP 130/76 mm Hg,혈갑1.76 mmol· L-1、대사성감중독。기간무연합용약,사갑공、신상선공능등미견이상。경보갑치료5 d후환자혈갑회복지4.22 mmol· L-1,대사성감중독규정。
One 51-year-old male patient with psoriasis arthritis developed elevation of AST and ALT and received compound glycyrrhizin tablets (2 tablets, tid) for the treatment of drug-induced hepatitis, which caused by methotrexate. After a week of the treatment, the patient developed weakness in lower legs and hard walking. After 2 weeks, he appeared edema in the face and lower extremity, and the blood pressure increased to 160/90 mm Hg. He suffered from upper limbs weakness and shivering, and the blood pressure was 160/90 mm Hg after 3 weeks of the treatment. After stopping use of compound glycyrrhizin for one week, the symptoms of weakness, hard walking and upper limb shaking relieved, the blood pressure returned to 130/76 mmHg, while the patient appeared hypokalemia with blood potassium 1.76 mmol?L-1 and metabolic alkalosis. The combination use of medication was not found. The functions of thyroid and adrenal were normal. After the treatment of potassium supplementation for 5 days, blood potassium recovered to 4.22 mmol?L-1, metabolic alkalosis was corrected.